Your browser doesn't support javascript.
loading
Preclinical and clinical investigation of intratumoral chemotherapy pharmacokinetics in DIPG using gemcitabine.
Green, Adam L; Flannery, Patrick; Hankinson, Todd C; O'Neill, Brent; Amani, Vladimir; DeSisto, John; Knox, Aaron; Chatwin, Hannah; Lemma, Rakeb; Hoffman, Lindsey M; Mulcahy Levy, Jean; Raybin, Jennifer; Hemenway, Molly; Gilani, Ahmed; Koschmann, Carl; Dahl, Nathan; Handler, Michael; Pierce, Angela; Venkataraman, Sujatha; Foreman, Nicholas; Vibhakar, Rajeev; Wempe, Michael F; Dorris, Kathleen.
Afiliación
  • Green AL; Morgan Adams Foundation Pediatric Brain Tumor Research Program, Aurora, Colorado, USA.
  • Flannery P; Center for Cancer and Blood Disorders, Children's Hospital Colorado, Aurora, Colorado, USA.
  • Hankinson TC; Department of Pediatrics, University of Colorado School of Medicine, Aurora, Colorado, USA.
  • O'Neill B; Morgan Adams Foundation Pediatric Brain Tumor Research Program, Aurora, Colorado, USA.
  • Amani V; Morgan Adams Foundation Pediatric Brain Tumor Research Program, Aurora, Colorado, USA.
  • DeSisto J; Center for Cancer and Blood Disorders, Children's Hospital Colorado, Aurora, Colorado, USA.
  • Knox A; Department of Neurosurgery, University of Colorado School of Medicine, Aurora, Colorado, USA.
  • Chatwin H; Morgan Adams Foundation Pediatric Brain Tumor Research Program, Aurora, Colorado, USA.
  • Lemma R; Department of Neurosurgery, University of Colorado School of Medicine, Aurora, Colorado, USA.
  • Hoffman LM; Morgan Adams Foundation Pediatric Brain Tumor Research Program, Aurora, Colorado, USA.
  • Mulcahy Levy J; Morgan Adams Foundation Pediatric Brain Tumor Research Program, Aurora, Colorado, USA.
  • Raybin J; Morgan Adams Foundation Pediatric Brain Tumor Research Program, Aurora, Colorado, USA.
  • Hemenway M; Morgan Adams Foundation Pediatric Brain Tumor Research Program, Aurora, Colorado, USA.
  • Gilani A; Morgan Adams Foundation Pediatric Brain Tumor Research Program, Aurora, Colorado, USA.
  • Koschmann C; Morgan Adams Foundation Pediatric Brain Tumor Research Program, Aurora, Colorado, USA.
  • Dahl N; Center for Cancer and Blood Disorders, Children's Hospital Colorado, Aurora, Colorado, USA.
  • Handler M; Department of Pediatrics, University of Colorado School of Medicine, Aurora, Colorado, USA.
  • Pierce A; Morgan Adams Foundation Pediatric Brain Tumor Research Program, Aurora, Colorado, USA.
  • Venkataraman S; Center for Cancer and Blood Disorders, Children's Hospital Colorado, Aurora, Colorado, USA.
  • Foreman N; Department of Pediatrics, University of Colorado School of Medicine, Aurora, Colorado, USA.
  • Vibhakar R; Morgan Adams Foundation Pediatric Brain Tumor Research Program, Aurora, Colorado, USA.
  • Wempe MF; Center for Cancer and Blood Disorders, Children's Hospital Colorado, Aurora, Colorado, USA.
  • Dorris K; Department of Pediatrics, University of Colorado School of Medicine, Aurora, Colorado, USA.
Neurooncol Adv ; 2(1): vdaa021, 2020.
Article en En | MEDLINE | ID: mdl-32642682
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Neurooncol Adv Año: 2020 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Neurooncol Adv Año: 2020 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Reino Unido